![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » DRUG-ELUTING STENTS MAY CAUSE MORE THAN 2,000 DEATHS PER YEAR, RESEARCHERS SAY
DRUG-ELUTING STENTS MAY CAUSE MORE THAN 2,000 DEATHS PER YEAR, RESEARCHERS SAY
October 12, 2006
An editorial on the American College of Cardiology (ACC) website supports recent studies showing that drug-eluting stents may pose a greater risk to patients than previously thought.
The editorial comes after the World Congress of Cardiology, where experts said the success of drug-eluting stents "comes at a price." Patients using the devices could be trading restenosis -- a rarely life-threatening condition where the coronary artery re-narrows -- for thrombosis, which may lead to heart attack or death, experts said.
The researchers in the ACC editorial estimated that, in the absence of a definitive clinical trial, "using [drug-eluting stents] in 80 percent out of 1 million percutaneous coronary intervention cases would translate into 2,160 excess deaths per year attributable to late stent thrombosis" in the U.S. -- "a risk far worse than that of tainted spinach no matter how profound the reduction in restenosis."
The editorial can be viewed at www.cardiosource.com/editorials/index.asp?EdID=87 (http://www.cardiosource.com/editorials/index.asp?EdID=87).
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct